Voloridge Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.35M Sell
171,188
-60,117
-26% -$1.47M 0.01% 752
2025
Q4
$6.19M Sell
231,305
-61,138
-21% -$1.57M 0.02% 709
2025
Q3
$7.79M Sell
292,443
-33,069
-10% -$854K 0.03% 617
2025
Q2
$7.47M Buy
325,512
+109,510
+51% +$2.72M 0.03% 637
2025
Q1
$6.26M Buy
216,002
+72,566
+51% +$2.32M 0.02% 718
2024
Q4
$5.33M Buy
143,436
+19,991
+16% +$914K 0.02% 761
2024
Q3
$5.99M Sell
123,445
-78,028
-39% -$3.42M 0.02% 736
2024
Q2
$8.06M Sell
201,473
-20,327
-9% -$842K 0.03% 625
2024
Q1
$9.74M Sell
221,800
-6,869
-3% -$355K 0.04% 497
2023
Q4
$14.1M Sell
228,669
-142,641
-38% -$7.49M 0.06% 390
2023
Q3
$17.1M Buy
371,310
+183,371
+98% +$10M 0.08% 317
2023
Q2
$10.8M Buy
187,939
+114,995
+158% +$5.1M 0.05% 443
2023
Q1
$2.74M Sell
72,944
-21,677
-23% -$711K 0.01% 889
2022
Q4
$2.65M Sell
94,621
-67,637
-42% -$1.96M 0.01% 895
2022
Q3
$4.56M Sell
162,258
-14,724
-8% -$481K 0.02% 681
2022
Q2
$6.16M Buy
176,982
+82,912
+88% +$2.96M 0.03% 600
2022
Q1
$3.38M Buy
+94,070
New +$2.67M 0.02% 783
2020
Q4
Sell
-45,541
Closed -$854K 1302
2020
Q3
$854K Buy
+45,541
New +$917K 0.01% 981

Other funds holding AMPH

Voloridge Investment Management's AMPH Position: Q1 2026 in Review

Voloridge Investment Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 26% in Q1 2026, selling an estimated $1.47M and leaving 171,188 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #752.

Voloridge Investment Management first reported a position in AMPH in Q3 2020 and has held it in 18 quarters since. The position peaked at $17.1M in Q3 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Voloridge Investment Management held 171,188 shares of Amphastar Pharmaceuticals worth $3.35M as of Q1 2026.
  • Voloridge Investment Management sold 60,117 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.47M.
  • Amphastar Pharmaceuticals made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #752 holding.
  • Voloridge Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2020 and has held it in 18 quarters since.
  • Voloridge Investment Management's Amphastar Pharmaceuticals position peaked at $17.1M in Q3 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.